Search Results - "Angiulli, Angelica"
-
1
Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming
Published in Proceedings of the National Academy of Sciences - PNAS (22-05-2007)“…The use of recombinant tumor antigen proteins is a realistic approach for the development of generic cancer vaccines, but the potential of this type of…”
Get full text
Journal Article -
2
Immunization of Malignant Melanoma Patients with Full-Length NY-ESO-1 Protein Using TLR7 Agonist Imiquimod as Vaccine Adjuvant
Published in The Journal of immunology (1950) (01-07-2008)“…T cell-mediated immunity to microbes and to cancer can be enhanced by the activation of dendritic cells (DCs) via TLRs. In this study, we evaluated the safety…”
Get full text
Journal Article -
3
Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using Toll-like receptor 7 agonist imiquimod as vaccine adjuvant
Published in The Journal of immunology (1950) (01-07-2008)“…T cell-mediated immunity to microbes and to cancer can be enhanced by the activation of dendritic cells (DCs) via Toll-like receptors (TLRs). In this study, we…”
Get full text
Journal Article